Canadian drug firm Duchesnay received U.S. federal approval for its Diclegis treatment to address nausea and vomiting in pregnant women. Severe drowsiness was the most frequent side effect.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||